Cargando…
Prominent Efficacy of Amantadine against Human Borna Disease Virus Infection In Vitro and In Vivo. Comment on Fink et al. Amantadine Inhibits SARS-CoV-2 In Vitro. Viruses 2021, 13, 539
Amantadine (1-amino-adamantane) is a versatile antiviral compound which has been licensed for decades against influenza viruses. During the Corona pandemic, its effect to inhibit SARS-CoV-2 in vitro has been investigated. However, an in vivo oral inapplicability was concluded due to ID(50) doses exc...
Autores principales: | Bode, Liv, Dietrich, Detlef E., Spannhuth, Carsten W., Ludwig, Hanns |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953669/ https://www.ncbi.nlm.nih.gov/pubmed/35336901 http://dx.doi.org/10.3390/v14030494 |
Ejemplares similares
-
Antiviral treatment perspective against Borna disease virus 1 infection in major depression: a double-blind placebo-controlled randomized clinical trial
por: Dietrich, Detlef E., et al.
Publicado: (2020) -
Word recognition memory and serum levels of Borna disease virus specific circulating immune complexes in obsessive–compulsive disorder
por: Zhang, Yuanyuan, et al.
Publicado: (2022) -
Efficacy of Combined Therapy with Amantadine, Oseltamivir, and Ribavirin In Vivo against Susceptible and Amantadine-Resistant Influenza A Viruses
por: Nguyen, Jack T., et al.
Publicado: (2012) -
Amantadine Inhibits SARS-CoV-2 In Vitro
por: Fink, Klaus, et al.
Publicado: (2021) -
Treatment Effectiveness of Amantadine Against Dengue Virus Infection
por: Lin, Chieh-Cheng, et al.
Publicado: (2016)